News
Discovery could open door to new COPD treatment
Research led by the Centenary Institute, the University of Technology Sydney and Ghent University Hospital, Belgium has identified a new therapeutic approach for chronic obstructive pulmonary disease (COPD).

-
New funding to advance gene therapies
Researchers at the Centenary Institute and the Sydney Local Health District (SLHD) have been awarded $500,000 from CUREator, Australia’s national biotech incubator, to develop new technology to improve the safe and effective delivery of gene therapy.News Type: Media releaseDate -
How can cardiovascular healthcare be ‘greener’?
A new review has shown how medical professionals in cardiology can help reduce healthcare’s carbon footprint, by making small, low-cost changes in how they work. The review, published today in the prestigious Open Heart journal, explores the environmental impact of cardiovascular healthcare.News Type: Media releaseDate -
Key mechanism identified for reducing chronic inflammation in cardiovascular diseases
A breakthrough discovery in understanding how white blood cells move in the body could pave the way for new treatments for chronic inflammation-related diseases including cardiovascular diseases, according to a recent study from the Centenary Institute.News Type: Media releaseDate -
Centenary Institute announces new Executive Director – a coup to recruit a shining star from Melbourne’s WEHI
The Centenary Institute is delighted to announce that Professor Marc Pellegrini will join the Centenary Institute as its new Executive Director. A physician, immunologist and internationally renowned research scientist, Professor Pellegrini has over 20 years of experience working on chronic infections.News Type: Media releaseDate -
Discovery could open door to new COPD treatment
Research led by the Centenary Institute, the University of Technology Sydney and Ghent University Hospital, Belgium has identified a new therapeutic approach for chronic obstructive pulmonary disease (COPD) – the targeting and inhibition of a protein called RIPK1.News Type: Media releaseDate -
Grant supports new COVID-19 nasal vaccine research
Research led by the Centenary Institute and the University of Sydney – focused on the development of a new nasal COVID-19 vaccine – has received close to $1m in grant funding from the NSW COVID-19 Vaccine Acceleration Research Grants Program.News Type: Media releaseDate -
Research boost for heart muscle disease
World-leading research into heart muscle disease has been boosted with the Centenary Institute’s Associate Professor Mathias Francois and team awarded a National Health and Medical Research Council (NHMRC) Ideas Grant to investigate left ventricular non compaction cardiomyopathy (LVNC).News Type: Media releaseDate -
Increased genetic testing required to identify concealed cardiomyopathy
Researchers from the Centenary Institute have found that concealed cardiomyopathy is an important cause of sudden cardiac death where no cause is found from autopsy – and that genetic testing can help identify cases of concealed cardiomyopathy which provides a cause of death and also helps guide care of surviving relatives.News Type: Media releaseDate -
New nasal vaccine strategy could improve COVID-19 protection
Researchers from the Centenary Institute and the University of Sydney have developed a new nasal vaccination strategy that induces potent lung immunity and protection against the SARS-CoV-2 coronavirus.News Type: Media releaseDate -
Genetic testing helps detect children likely to have heart failure and require a transplant
Genetic testing can diagnose cardiomyopathy – a disease of the heart muscle – in children and help detect who will have heart failure and require a transplant, a new study has found.News Type: Media releaseDate -
New funding to accelerate research into sudden cardiac death
Centenary Institute researchers in the Agnes Ginges Centre for Molecular Cardiology have secured $2.7 million in funding for nationally significant research into cardiovascular disease and sudden cardiac death.News Type: Media releaseDate -
New vaccine research aims to conquer TB
The Centenary Institute and the University of Sydney, together with collaborators, have been awarded an AU$19 million contract from the National Institute of Allergy and Infectious Diseases, part of the US National Institutes of Health (NIH), to develop the next generation of tuberculosis (TB) vaccines.News Type: Media releaseDate